Effect of Pulmonary Rehabilitation in Lung Cancer Survivors

• Six minute walk test to assess exercise tolerance [ Time Frame: Within 3 month of discharge from surgery ] [ Designated as safety issue: Yes ]
  

• Shoulder Range of Motion Changes [ Time Frame: Within 3 months of discharge from surgery ] [ Designated as safety issue: No ]
  
• Bioimpedence for tissue composition [ Time Frame: Within 3 months of discharge from surgery ] [ Designated as safety issue: No ]
  
• Quality of life measurement changes [ Time Frame: Within 3 months of discharge from surgery ] [ Designated as safety issue: No ]
  

The research question is to investigate

• whether patients who have undergone curative surgical resection for lung cancer benefit from 8 weeks of early outpatient pulmonary rehabilitation (started within 2 weeks of hospital discharge).
• to identify potential barriers to this approach

Pulmonary rehabilitation (PR) is the most effective non-pharmacological treatment for patients with chronic respiratory diseases, especially COPD. Many patients with lung cancer have co-existing smoking-related lung disorders such as COPD. To date there have been no randomised controlled trials of PR in post-resection lung cancer survivors. However there is indirect evidence that PR may be of benefit in this patient cohort. Cesario et al (2007)reported a 32% improvement in exercise capacity with in-patient PR, and Spruit et al (2009) demonstrated a 43% improvement in six minute walk distance following an 8-week in-patient PR programme. However, both studies had small numbers, and no randomised control group. Furthermore, inpatient PR is not an economically justifiable intervention in the NHS where emphasis is on self-management and ambulatory care.